Management of hepatitis B and C infections in rheumatologic disease

被引：3

作者：

Cheah, Jonathan T. L. ^{[1
]}

Faragon, John J. ^{[2
]}

Marks, Kristen M. ^{[3
]}

机构：

[1] Hosp Special Surg, Dept Med, 535 E 70th St, New York, NY 10021 USA

[2] Albany Med Ctr, Dept Pharm & Med, 43 New Scotland Ave, Albany, NY 12208 USA

[3] Weill Cornell Med, Div Infect Dis, 525 East 70th St, New York, NY 10065 USA

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2018年 / 32卷 / 06期

关键词：

Hepatitis B; Hepatitis C; Vasculitis; Polyarteritis nodosa; Cryoglobulinemic vasculitis; Direct-acting antivirals; Sicca syndrome; Arthritis; Drug interactions; TENOFOVIR DISOPROXIL FUMARATE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HCV GENOTYPE 1; VIRUS-INFECTION; POLYARTERITIS-NODOSA; MIXED CRYOGLOBULINEMIA; SJOGREN-SYNDROME; SURFACE-ANTIGEN; EXTRAHEPATIC MANIFESTATIONS; ANKYLOSING-SPONDYLITIS;

D O I：

10.1016/j.berh.2019.04.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hepatitis B and C viruses present dual considerations in rheumatic disease as both etiologic factors and important comorbidities that must be assessed and addressed. This review summarizes the link between hepatitis B and arthritis and polyarteritis nodosa as well as hepatitis C and arthritis, Sicca syndrome and cryoglobulinemic vasculitis. Recent data pertaining to the antiviral management in these conditions, especially regarding the use of the direct-acting antivirals in hepatitis C, are also presented. Additionally, guidance on testing and treatment of hepatitis B and C as comorbidities in the context of systemic inflammatory rheumatic conditions and the use of disease-modifying antirheumatic therapy are discussed. (C) 2019 Elsevier Ltd. All rights reserved.

引用

页码：848 / 868

页数：21

共 50 条

[21] Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors [J].

Mustafayev, Khalis ;

Mallet, Vincent ;

Torres, Harrys A. .

JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2024, 7 (02) :111-121

[22] Screening Indicators of Hepatitis A, Hepatitis B, Hepatitis C and HIV infections in Prisoners [J].

Balci, Elcin ;

Turker, Kamuran ;

Senol, Vesile ;

Gunay, Osman .

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2012, 18 (02) :64-67

[23] Extrahepatic Manifestations of Hepatitis B [J].

Najafian, Nilofar ;

Han, Steven-Huy .

CURRENT HEPATOLOGY REPORTS, 2023, 22 (03) :147-157

[24] Diagnosis and Management of Hepatitis B and C [J].

Pardee, Michelle .

NURSING CLINICS OF NORTH AMERICA, 2019, 54 (02) :277-+

[25] Management of hepatitis B during pregnancy [J].

Kar, Premashis ;

Mishra, Saurabh .

EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (03) :301-310

[26] Prevalence of hepatitis b and c infections in patients on hemodialysis [J].

Balode, Ashwini A. ;

Khan, Zia H. .

BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2010, 3 (02) :154-158

[27] Rheumatoid Factors in Hepatitis B and C Infections: Connecting Viruses, Autoimmunity, and Cancer [J].

Moll, Jakub ;

Isailovic, Natasa ;

De Santis, Maria ;

Selmi, Carlo .

ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (07) :480-486

[28] Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease [J].

Soi, Vivek ;

Daifi, Chantale ;

Yee, Jerry ;

Adams, Elizabeth .

ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (01) :41-50

[29] Management of patients with hepatitis B in special populations [J].

Cholongitas, Evangelos ;

Tziomalos, Konstantinos ;

Pipili, Chrysoula .

WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) :1738-1748

[30] Unmet need in chronic hepatitis B management [J].

Liang, Lilian Yan ;

Wong, Grace Lai-Hung .

CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (02) :172-180

← 1 2 3 4 5 →